Spotlight

UCL cancer immunotherapy company, Autolus, launches with £30m investment

A new UCL spin-out company – Autolus – is being launched today to develop and commercialise a new generation of engineered T-cell therapies for haematological and solid tumours, with the backing of £30m in investment from healthcare investment company Syncona.

Find out more



follow us on twitter


MOOCs or campus? In the future, you choose

20 May 2013

By Stephen Caddick, Vice-Provost (Enterprise) at UCL
A napster moment; the end of boring lectures; a tipping point. These are all common responses to the emergence of MOOCs – Massive Open Online Courses. Now, simply using a laptop or iPad, hundreds of thousands of students can tune in to lectures from anywhere around the globe

Read the full article at theconversation.com